{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:06:22Z","timestamp":1792659982235,"version":"4.5.0"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/gme.0b013e31803c764d","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T08:02:57Z","timestamp":1177574577000},"page":"373-384","source":"Crossref","is-referenced-by-count":151,"title":["Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression"],"prefix":"10.1097","volume":"14","author":[{"given":"Thomas B.","family":"Clarkson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210227","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"R2-11-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women-principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R3-11-20210227","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.ATV.10.6.1051","article-title":"Inhibition of coronary artery atherosclerosis by 17- estradiol in ovariectomized monkeys. Lack of an effect of added progesterone.","volume":"10","author":"Adams","year":"1990","journal-title":"Arteriosclerosis"},{"key":"R4-11-20210227","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.ATV.17.1.217","article-title":"Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis.","volume":"17","author":"Adams","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R5-11-20210227","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1210\/jcem.86.11.8021","article-title":"A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys.","volume":"86","author":"Clarkson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-11-20210227","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM198510243131703","article-title":"A prospective study of postmenopausal estrogen therapy and coronary heart disease.","volume":"313","author":"Stampfer","year":"1985","journal-title":"N Engl J Med"},{"key":"R7-11-20210227","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-133-12-200012190-00008","article-title":"A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.","volume":"133","author":"Grodstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"R8-11-20210227","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/01.CIR.103.11.1546","article-title":"Effects of nonlipid factors on atherosclerosis in youth with a favorable lipoprotein profile.","volume":"103","author":"McGill","year":"2001","journal-title":"Circulation"},{"key":"R9-11-20210227","first-page":"157","article-title":"Sex and atherosclerosis.","volume":"4","author":"McGill","year":"1979","journal-title":"Atheroscler Rev"},{"key":"R10-11-20210227","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.STR.29.6.1116","article-title":"Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause.","volume":"29","author":"Sutton-Tyrrell","year":"1998","journal-title":"Stroke"},{"key":"R11-11-20210227","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/01.CIR.103.22.2705","article-title":"High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound.","volume":"103","author":"Tuzcu","year":"2001","journal-title":"Circulation"},{"key":"R12-11-20210227","first-page":"509","article-title":"Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex.","volume":"18","author":"Tejada","year":"1968","journal-title":"Lab Invest"},{"key":"R13-11-20210227","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/01.CIR.101.8.850","article-title":"Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography.","volume":"101","author":"Raggi","year":"2000","journal-title":"Circulation"},{"key":"R15-11-20210227","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.ATV.17.1.95","article-title":"Effects of serum lipoproteins and smoking on atherosclerosis in young men and women.","volume":"17","author":"McGill","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-11-20210227","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(83)90040-0","article-title":"Effects of gender and social behavior on the development of coronary artery atherosclerosis in cynomolgus macaques.","volume":"48","author":"Hamm","year":"1983","journal-title":"Atherosclerosis"},{"key":"R17-11-20210227","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0031-9384(85)90262-8","article-title":"Psychosocial influences on ovarian endocrine and ovulatory function in Macaca fascicularis.","volume":"35","author":"Adams","year":"1985","journal-title":"Physiol Behav"},{"key":"R18-11-20210227","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0021-9150(84)90129-1","article-title":"Psychosocial influences on female \"protection\" among cynomolgus macaques.","volume":"53","author":"Kaplan","year":"1984","journal-title":"Atherosclerosis"},{"key":"R19-11-20210227","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00006842-199611000-00008","article-title":"Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models.","volume":"58","author":"Kaplan","year":"1996","journal-title":"Psychosom Med"},{"key":"R20-11-20210227","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.ATV.14.5.721","article-title":"Social status and coronary artery atherosclerosis in female monkeys.","volume":"14","author":"Shively","year":"1994","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R21-11-20210227","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.CIR.90.2.983","article-title":"Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis.","volume":"90","author":"Williams","year":"1994","journal-title":"Circulation"},{"key":"R22-11-20210227","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.15.12.2094","article-title":"Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys.","volume":"15","author":"Kaplan","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R23-11-20210227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ilar.45.2.89","article-title":"Ovarian dysfunction, stress, and disease: a primate continuum.","volume":"44","author":"Kaplan","year":"2004","journal-title":"ILAR J"},{"key":"R24-11-20210227","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0735-1097(02)02763-8","article-title":"Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE Study.","volume":"41","author":"Merz","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R25-11-20210227","first-page":"511","article-title":"Estradiol concentrations in premenopausal women with coronary heart disease.","volume":"8","author":"Hanke","year":"1997","journal-title":"Coron Artery Dis"},{"key":"R26-11-20210227","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.fertnstert.2006.01.009","article-title":"Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.","volume":"85","author":"Merz","year":"2006","journal-title":"Fertil Steril"},{"key":"R27-11-20210227","first-page":"53","article-title":"Hormone replacement therapy and coronary artery atherosclerosis: the monkey model.","volume":"103","author":"Clarkson","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"R28-11-20210227","first-page":"41","article-title":"Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens.","volume":"86","author":"Clarkson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-11-20210227","first-page":"61","article-title":"The new conundrum: do estrogens have any cardiovascular benefits.","volume":"47","author":"Clarkson","year":"2002","journal-title":"Int J Fertil"},{"key":"R30-11-20210227","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","article-title":"Hormone therapy to prevent disease and prolong life in postmenopausal women.","volume":"117","author":"Grady","year":"1992","journal-title":"Ann Intern Med"},{"key":"R31-11-20210227","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.","volume":"15","author":"Grodstein","year":"2006","journal-title":"J Womens Health"},{"key":"R32-11-20210227","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-135-11-200112040-00005","article-title":"Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial.","volume":"135","author":"Hodis","year":"2001","journal-title":"Ann Intern Med"},{"key":"R33-11-20210227","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease.","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"R34-11-20210227","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogens in postmenopausal women with hysterectomy-the WHI randomized controlled trial.","volume":"291","year":"2004","journal-title":"JAMA"},{"key":"R35-11-20210227","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Brief report: coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.","volume":"21","author":"Salpter","year":"2006","journal-title":"J Gen Intern Med"},{"key":"R36-11-20210227","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","article-title":"Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.","volume":"325","author":"Walsh","year":"1991","journal-title":"N Engl J Med"},{"key":"R37-11-20210227","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-2008-1026621","article-title":"Prevention of atherosclerosis by estrogen substitution?","volume":"48","author":"Kuhl","year":"1988","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R38-11-20210227","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.75.6.1102","article-title":"Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.","volume":"75","author":"Bush","year":"1987","journal-title":"Circulation"},{"key":"R39-11-20210227","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial.","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R40-11-20210227","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0039-128X(00)00174-4","article-title":"Progestins and cardiovascular risk markers.","volume":"65","author":"Sitruk-Ware","year":"2000","journal-title":"Steroids"},{"key":"R41-11-20210227","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0039-128X(03)00123-5","article-title":"MPA and postmenopausal coronary artery atherosclerosis revisited.","volume":"68","author":"Clarkson","year":"2003","journal-title":"Steroids"},{"key":"R43-11-20210227","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/01.GME.0000153934.76086.A4","article-title":"Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial.","volume":"12","author":"Karim","year":"2005","journal-title":"Menopause"},{"key":"R44-11-20210227","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0015-0282(97)81856-0","article-title":"Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein.","volume":"67","author":"Wilcox","year":"1997","journal-title":"Fertil Steril"},{"key":"R45-11-20210227","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00042192-200111000-00005","article-title":"Comparison of the antioxidant effects of equine estrogens, red women components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.","volume":"8","author":"Bhavnani","year":"2001","journal-title":"Menopause"},{"key":"R46-11-20210227","first-page":"1095","article-title":"Antioxidant potential of specific estrogens on lipid peroxidation.","volume":"77","author":"Subbiah","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-11-20210227","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system.","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"key":"R48-11-20210227","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/01.CIR.96.6.1970","article-title":"Contrasting effects of conjugated estrogens and tamoxifen on dilator responses of atherosclerotic epicardial coronary arteries in nonhuman primates.","volume":"96","author":"Williams","year":"1997","journal-title":"Circulation"},{"key":"R49-11-20210227","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.physiol.67.040403.120151","article-title":"Regulation of signal transduction pathways by estrogen and progesterone.","volume":"67","author":"Edwards","year":"2005","journal-title":"Annu Rev Physiol"},{"key":"R50-11-20210227","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0008-6363(01)00473-4","article-title":"Endothelial function, vascular reactivity and gender differences in the cardiovascular system.","volume":"15","author":"Sader","year":"2002","journal-title":"Cardiovasc Res"},{"key":"R51-11-20210227","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis.","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"R52-11-20210227","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis.","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"R53-11-20210227","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tem.2004.01.005","article-title":"Estrogen, inflammation and cardiovascular risk in women: a critical appraisal.","volume":"15","author":"Stork","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"R54-11-20210227","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0021-9150(02)00242-3","article-title":"The effect of 17-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial.","volume":"165","author":"Stork","year":"2002","journal-title":"Atherosclerosis"},{"key":"R55-11-20210227","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0008-6363(01)00461-8","article-title":"The effect of 17-estradiol on MCP-1 serum levels in postmenopausal women.","volume":"53","author":"Stork","year":"2002","journal-title":"Cardiovasc Res"},{"key":"R56-11-20210227","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","article-title":"Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) study.","volume":"100","author":"Cushman","year":"1999","journal-title":"Circulation"},{"key":"R57-11-20210227","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/01.CIR.100.18.1851","article-title":"Vascular effects of estrogen and vitamin E therapies in postmenopausal women.","volume":"100","author":"Koh","year":"1999","journal-title":"Circulation"},{"key":"R58-11-20210227","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.CIR.99.3.354","article-title":"Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women.","volume":"99","author":"Koh","year":"1999","journal-title":"Circulation"},{"key":"R59-11-20210227","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0037-1614551","article-title":"Hormone replacement therapy and circulating ICAM-1 in postmenopausal women. A randomized controlled trial.","volume":"81","author":"Scarabin","year":"1999","journal-title":"Thromb Haemost"},{"key":"R60-11-20210227","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0002-9149(00)01116-4","article-title":"Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women.","volume":"86","author":"Blum","year":"2000","journal-title":"Am J Cardiol"},{"key":"R61-11-20210227","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/euhj.1999.1988","article-title":"Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease.","volume":"21","author":"Sbarouni","year":"2000","journal-title":"Eur Heart J"},{"key":"R62-11-20210227","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(00)00952-9","article-title":"Divergent effects of hormone therapy on serum markers if inflammation in postmenopausal women with coronary artery disease on appropriate medical management.","volume":"36","author":"Zanger","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R63-11-20210227","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1055\/s-0037-1613947","article-title":"Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease.","volume":"83","author":"Seljeflot","year":"2000","journal-title":"Thromb Haemost"},{"key":"R64-11-20210227","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-5122(02)00182-2","article-title":"Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women.","volume":"43","author":"Goudev","year":"2002","journal-title":"Maturitas"},{"key":"R65-11-20210227","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/01.CIR.0000013837.81710.DA","article-title":"Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women.","volume":"105","author":"Koh","year":"2002","journal-title":"Circulation"},{"key":"R66-11-20210227","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-9150(03)00012-1","article-title":"Circulating markers of inflammation and atherosclerosis.","volume":"169","author":"Lind","year":"2003","journal-title":"Atherosclerosis"},{"key":"R67-11-20210227","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1112062","article-title":"Molecular and cellular basis of cardiovascular gender differences.","volume":"308","author":"Mendelsohn","year":"2005","journal-title":"Science"},{"key":"R68-11-20210227","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.ATV.15.7.827","article-title":"Regression of atherosclerosis in female monkeys.","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R69-11-20210227","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary artery atherosclerosis.","volume":"343","author":"Herrington","year":"2000","journal-title":"N Engl J Med"},{"key":"R70-11-20210227","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa030830","article-title":"Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.","volume":"349","author":"Hodis","year":"2003","journal-title":"N Engl J Med"},{"key":"R71-11-20210227","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/01.CIR.89.4.1501","article-title":"Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women.","volume":"89","author":"Losordo","year":"1994","journal-title":"Circulation"},{"key":"R72-11-20210227","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0008-6363(99)00153-4","article-title":"Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system.","volume":"43","author":"Post","year":"1999","journal-title":"Cardiovasc Res"},{"key":"R73-11-20210227","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/hc0402.102860","article-title":"Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration.","volume":"105","author":"Campisi","year":"2002","journal-title":"Circulation"},{"key":"R74-11-20210227","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0735-1097(01)01566-2","article-title":"Vascular effects of estrogen in type II diabetic postmenopausal women.","volume":"38","author":"Koh","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R75-11-20210227","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/hq1201.100241","article-title":"Estrogen replacement and brachial artery flow-mediated vasodilation in older women.","volume":"21","author":"Herrington","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R76-11-20210227","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1385\/ENDO:24:3:251","article-title":"Postmenopausal hormone therapy: lessons from observation and randomized studies.","volume":"24","author":"Rosano","year":"2004","journal-title":"Endocrine"},{"key":"R77-11-20210227","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2004.11.012","article-title":"Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis.","volume":"83","author":"Phillips","year":"2005","journal-title":"Fertil Steril"},{"key":"R78-11-20210227","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","article-title":"Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.","volume":"89","author":"van der Wal","year":"1994","journal-title":"Circulation"},{"key":"R79-11-20210227","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.CIR.90.2.775","article-title":"Macrophage infiltration in acute coronary syndromes: implications for plaque rupture.","volume":"90","author":"Moreno","year":"1994","journal-title":"Circulation"},{"key":"R80-11-20210227","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/bies.950140705","article-title":"The matrix degrading metalloproteinases.","volume":"14","author":"Matrisian","year":"1992","journal-title":"Bioessays"},{"key":"R81-11-20210227","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0021-9150(94)93771-0","article-title":"Effect of acetyl-LDL on monocyte\/macrophage expression of matrix metalloproteinases Abstract.","volume":"109","author":"Rennick","year":"1994","journal-title":"Atherosclerosis"},{"key":"R82-11-20210227","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1095\/biolreprod.103.015933","article-title":"Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.","volume":"69","author":"Goffin","year":"2003","journal-title":"Biol Reprod"},{"key":"R83-11-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.141R001","article-title":"Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation.","volume":"141","author":"Hampton","year":"1994","journal-title":"J Endocrinol"},{"key":"R84-11-20210227","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1242\/jcs.109.8.2151","article-title":"Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium.","volume":"109","author":"Kokorine","year":"1996","journal-title":"J Cell Sci"},{"key":"R85-11-20210227","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1161\/01.CIR.0000019406.74017.B2","article-title":"Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen\/Progestin Replacement Study (HERS).","volume":"105","author":"Herrington","year":"2002","journal-title":"Circulation"},{"key":"R86-11-20210227","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.ATV.0000068646.76823.AE","article-title":"Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.","volume":"23","author":"Luan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R87-11-20210227","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2005.11.026","article-title":"Role of annexin II in estrogen-induced macrophage matrix metalloproteinase-9 activity: the modulating effect of statins.","volume":"189","author":"Hwang","year":"2006","journal-title":"Atherosclerosis"},{"key":"R88-11-20210227","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2005.06.011","article-title":"The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.","volume":"185","author":"Hu","year":"2006","journal-title":"Atherosclerosis"},{"key":"R89-11-20210227","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1210\/jc.2005-2789","article-title":"Effects of hormone replacement therapy type and route of administration on plasma matrix metalloproteinases and their tissue inhibitors in postmenopausal women.","volume":"91","author":"Lewandowski","year":"2006","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-200714030-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T22:26:00Z","timestamp":1628807160000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200714030-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31803c764d","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}